November 12, 2019
The Phase 1/2 clinical trial of AVB-500 is being done in combination with durvalumab in patients with ovarian cancer.
October 8, 2019
With Q4 in full swing, it's time to reflect on the top-performing NASDAQ pharma stocks year-to-date.
October 2, 2019
The company's inhaler therapy, Trelegy Ellipta, has already been approved in the US for chronic obstructive pulmonary disease.
August 29, 2019
The victory comes almost exactly a year after AstraZeneca's lupus treatment didn't meet its primary endpoints in a different trial.
July 4, 2019
What are the biggest names in biotechnology? We count down the five top biotech stocks based on market cap and...
April 18, 2019
With Q1 2019 officially over, the Investing News Network shares a pharma market update on the biggest news and trends...
March 26, 2019
A report by Cortellis says that seven drugs entering the market in 2019 are projected to reach blockbuster status by...